GuidelineRadiation and environmental biophysics2026
The revised German guideline on the monitoring for intakes of radionuclides.
Guideline in Radiation and environmental biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2025, the guideline for the realisation of monitoring of occupational intakes of radionuclides (internal monitoring) in Germany was revised. For this purpose, an expert workgroup was mandated to consider the amended German radiation protection legislation, amended international standards and recommendations as well as other recent developments in the subject area. The methodology of the revised guideline for the calculation of the likely committed effective dose based on the handled activity and incorporation factors adapts international recommendations and standards. However, the definitions and values of the subfactors from which the incorporation factors are calculated deviate from international recommendations, for example the physical form safety factor considers the volume or mass of the handled radioactive material. For applications in nuclear medicine, specific incorporation factors based on recent literature are tabulated. Regarding the monitoring of persons of childbearing potential, an assessment of the equivalent dose for the uterus and if required a monthly monitoring are prescribed. Quality assurance of approved monitoring services is based optionally on accreditation or on audits by public authorities. For workplace monitoring, technical requirements, in particular quality-assurance procedures, are also specified. Regarding the dose assessment, a reference method and several individual methods are described, with the investigation threshold for changing to individual methods corresponding to an effective dose of 6 mSv during the calendar year. For the reference method, standard assumptions (inhalation, AMAD 5 μm for workplaces, 1 μm for emergency workers with environmental exposure) are applied.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.